antibody deficiency disease

an·ti·bod·y de·fi·cien·cy syn·drome

any of a group of disorders associated with a defective antibody production resulting from defects in the B-type lymphocyte system or in T-type lymphocytes; the chief manifestation is an increased susceptibility to infection by various microorganisms. See: agammaglobulinemia, hypogammaglobulinemia, immunodeficiency.

antibody deficiency disease

A nonspecific term for any B-cell immunodeficiency
References in periodicals archive ?
Key factors driving the market growth include approvals for IVIG therapy from FDA, EMA, and government, increase in awareness about IVIG treatment, rise in incidence of antibody deficiency diseases and hemophilic patients, and emergence of technologically advanced IVIG products.